Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.

1996; National Institutes of Health; Volume: 13; Issue: 1 Linguagem: Inglês

Autores

Hikaru Sonoda, Kazuyo Nishida, Takayuki Yoshioka, Misato Ohtani, Kenji Sugita,

Tópico(s)

Pharmacology and Nanomedicine Research

Referência(s)